Melatonin—widely available over the counter and often perceived as
“natural and safe”—has become increasingly used by caregivers to
address sleep disturbances in children and adolescents, yet its proper
role and safety profile in pediatrics remain nuanced and evolving. This
course examines current evidence on indications such as insomnia and
circadian rhythm sleep disorders, highlights concerns about
unregulated supplement use and adverse effects, and reviews practical
considerations for safe and informed use in pediatric patients. You will
gain insight into how to support caregivers with balanced counseling,
emphasize behavioral and environmental strategies, and apply clinical
judgment when melatonin is being considered for sleep management
in pediatric patients.
HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact
GUEST
Monica Bogenschutz, PharmD, BCPS, BCPPS, DPLA, FPPA
Pediatric Clinical Pharmacist and PGY2 Pediatric Pharmacy Residency Program Director at UW Health
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/
PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe common pediatric indications and available evidence for
melatonin use in children and adolescents
2. Identify pharmacist considerations related to safety, dosing,
behavioral counseling, and monitoring when melatonin is
recommended or used in pediatric patients.
Rachel Maynard and Monica Bogenschutz have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr
UAN: 0107-0000-26-222-H01-P
Initial release date: 5/25/2026
Expiration date: 5/25/2027
Additional CPE details can be found here.
